Recurrent urinary tract infection associated with <scp>SGLT</scp>‐2 inhibitor in type 2 diabetes mellitus patient: A case report

Hazique, Mohammad; Surana, Arihant; Sinha, Mehul; Anand, Ayush

doi:10.1002/ccr3.6803

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, definitive evidence supporting this correlation was not established. The case involved a type 2 diabetic patient who experienced a urinary infection while on empagliflozin and eventually showed clinical improvement on cessation of the drug [ 16 ]. Notably, the patient's condition improved after the drug was discontinued.…”

Section: Discussionmentioning

confidence: 99%

A Case Study of Emphysematous Cystitis in a Non-diabetic Patient Following Empagliflozin Use: An Uncommon Presentation

Busuttil,

Khalaf,

Galea

et al. 2024

Cureus

View full text Add to dashboard Cite

Emphysematous cystitis (EC), a rare urinary tract infection characterized by gas accumulation in the bladder walls, is predominantly seen in diabetic patients. This case study discusses an 83-year-old non-diabetic male with end-stage heart failure who presented with symptoms of EC after being administered empagliflozin. The unique presentation suggests a possible link between empagliflozin and EC in non-diabetic heart failure patients, a connection previously undocumented in medical literature, emphasizing the importance of vigilant monitoring and further research in this area.

show abstract

Section: Discussionmentioning

confidence: 99%